Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma

SIMPLE SUMMARY: Most glioblastoma patients succumb to the disease within 12 to 18 months, and only 9% are alive 2 years after diagnosis. Even with extensive research, the life expectancy of glioblastoma patients has not changed in decades. We aimed to identify differences in the transcriptomic profi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorokin, Maxim, Raevskiy, Mikhail, Zottel, Alja, Šamec, Neja, Skoblar Vidmar, Marija, Matjašič, Alenka, Zupan, Andrej, Mlakar, Jernej, Suntsova, Maria, Kuzmin, Denis V., Buzdin, Anton, Jovčevska, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303503/
https://www.ncbi.nlm.nih.gov/pubmed/34298634
http://dx.doi.org/10.3390/cancers13143419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303503/
https://www.ncbi.nlm.nih.gov/pubmed/34298634
http://dx.doi.org/10.3390/cancers13143419

Ejemplares similares